Susquehanna International Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,200
| Closed | -$154K | – | 13104 |
|
|
2024
Q4 | $154K | Sell |
11,200
-56,600
| -83% | -$1.04M | ﹤0.01% | 10998 |
|
|
2024
Q3 | $1.86M | Buy |
67,800
+3,000
| +5% | +$81.2K | ﹤0.01% | 5411 |
|
|
2024
Q2 | $1.59M | Buy |
64,800
+30,400
| +88% | +$667K | ﹤0.01% | 5554 |
|
|
2024
Q1 | $733K | Buy |
+34,400
| New | +$739K | ﹤0.01% | 7602 |
|
|
2023
Q4 | – | Sell |
-26,600
| Closed | -$427K | – | 12960 |
|
|
2023
Q3 | $427K | Buy |
26,600
+9,200
| +53% | +$175K | ﹤0.01% | 8596 |
|
|
2023
Q2 | $403K | Buy |
17,400
+3,200
| +23% | +$69.8K | ﹤0.01% | 8812 |
|
|
2023
Q1 | $330K | Buy |
+14,200
| New | +$288K | ﹤0.01% | 9502 |
|
|
2022
Q4 | – | Sell |
-31,700
| Closed | -$605K | – | 13235 |
|
|
2022
Q3 | $605K | Buy |
31,700
+18,500
| +140% | +$425K | ﹤0.01% | 7972 |
|
|
2022
Q2 | $240K | Sell |
13,200
-2,100
| -14% | -$43.6K | ﹤0.01% | 10165 |
|
|
2022
Q1 | $386K | Sell |
15,300
-42,500
| -74% | -$1.09M | ﹤0.01% | 9634 |
|
|
2021
Q4 | $1.59M | Sell |
57,800
-18,200
| -24% | -$527K | ﹤0.01% | 6057 |
|
|
2021
Q3 | $2.45M | Buy |
76,000
+14,100
| +23% | +$468K | ﹤0.01% | 5394 |
|
|
2021
Q2 | $1.89M | Buy |
61,900
+2,600
| +4% | +$75.1K | ﹤0.01% | 6042 |
|
|
2021
Q1 | $1.81M | Buy |
59,300
+16,600
| +39% | +$471K | ﹤0.01% | 6168 |
|
|
2020
Q4 | $844K | Buy |
42,700
+13,500
| +46% | +$218K | ﹤0.01% | 7097 |
|
|
2020
Q3 | $381K | Sell |
29,200
-25,400
| -47% | -$321K | ﹤0.01% | 8234 |
|
|
2020
Q2 | $619K | Buy |
54,600
+28,800
| +112% | +$409K | ﹤0.01% | 6915 |
|
|
2020
Q1 | $369K | Sell |
25,800
-30,500
| -54% | -$644K | ﹤0.01% | 7575 |
|
|
2019
Q4 | $1.53M | Sell |
56,300
-39,400
| -41% | -$1.08M | ﹤0.01% | 4765 |
|
|
2019
Q3 | $2.74M | Buy |
95,700
+31,700
| +50% | +$924K | ﹤0.01% | 3643 |
|
|
2019
Q2 | $1.78M | Buy |
64,000
+40,600
| +174% | +$1.15M | ﹤0.01% | 4415 |
|
|
2019
Q1 | $777K | Buy |
23,400
+11,300
| +93% | +$344K | ﹤0.01% | 5488 |
|
|
2018
Q4 | $352K | Sell |
12,100
-70,500
| -85% | -$2.54M | ﹤0.01% | 6712 |
|
|
2018
Q3 | $3.8M | Buy |
82,600
+36,800
| +80% | +$1.64M | ﹤0.01% | 3034 |
|
|
2018
Q2 | $1.71M | Sell |
45,800
-54,200
| -54% | -$1.83M | ﹤0.01% | 4283 |
|
|
2018
Q1 | $2.96M | Buy |
100,000
+32,800
| +49% | +$1.11M | ﹤0.01% | 3280 |
|
|
2017
Q4 | $2.31M | Sell |
67,200
-12,000
| -15% | -$405K | ﹤0.01% | 3651 |
|
|
2017
Q3 | $2.87M | Buy |
79,200
+21,000
| +36% | +$599K | ﹤0.01% | 3300 |
|
|
2017
Q2 | $1.5M | Buy |
58,200
+10,800
| +23% | +$229K | ﹤0.01% | 4425 |
|
|
2017
Q1 | $910K | Buy |
47,400
+35,900
| +312% | +$636K | ﹤0.01% | 5329 |
|
|
2016
Q4 | $192K | Sell |
11,500
-84,400
| -88% | -$1.53M | ﹤0.01% | 8676 |
|
|
2016
Q3 | $1.97M | Buy |
95,900
+19,700
| +26% | +$500K | ﹤0.01% | 3592 |
|
|
2016
Q2 | $2.33M | Buy |
76,200
+45,500
| +148% | +$1.58M | ﹤0.01% | 3315 |
|
|
2016
Q1 | $1.15M | Sell |
30,700
-17,600
| -36% | -$663K | ﹤0.01% | 4800 |
|
|
2015
Q4 | $2.08M | Sell |
48,300
-25,900
| -35% | -$1.09M | ﹤0.01% | 3950 |
|
|
2015
Q3 | $2.78M | Sell |
74,200
-10,100
| -12% | -$358K | ﹤0.01% | 3640 |
|
|
2015
Q2 | $2.87M | Buy |
84,300
+16,900
| +25% | +$575K | ﹤0.01% | 3943 |
|
|
2015
Q1 | $2.39M | Sell |
67,400
-182,000
| -73% | -$6.51M | ﹤0.01% | 3977 |
|
|
2014
Q4 | $8.49M | Sell |
249,400
-16,500
| -6% | -$585K | ﹤0.01% | 2214 |
|
|
2014
Q3 | $10.3M | Sell |
265,900
-107,000
| -29% | -$3.99M | ﹤0.01% | 2086 |
|
|
2014
Q2 | $14.5M | Sell |
372,900
-507,100
| -58% | -$18.9M | 0.01% | 1703 |
|
|
2014
Q1 | $30.1M | Sell |
880,000
-82,600
| -9% | -$2.56M | 0.01% | 938 |
|
|
2013
Q4 | $20.2M | Buy |
962,600
+520,600
| +118% | +$13.2M | 0.01% | 1349 |
|
|
2013
Q3 | $10.4M | Buy |
442,000
+77,500
| +21% | +$2.2M | 0.01% | 1860 |
|
|
2013
Q2 | $9.79M | Buy |
+364,500
| New | +$10.6M | 0.01% | 1816 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
Susquehanna International Group's MYGN Position: Q1 2026 in Review
Susquehanna International Group increased its Myriad Genetics (MYGN) stake by 416% in Q1 2026, buying an estimated $1.36M and bringing the position to 323,519 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #6969.
Susquehanna International Group first reported a position in MYGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $12M in Q4 2013. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- Susquehanna International Group held 323,519 shares of Myriad Genetics worth $1.46M as of Q1 2026.
- Susquehanna International Group bought 260,841 Myriad Genetics shares in Q1 2026, an estimated $1.36M.
- Myriad Genetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6969 holding.
- Susquehanna International Group first reported a position in Myriad Genetics in Q2 2013 and has held it in 44 quarters since.
- Susquehanna International Group's Myriad Genetics position peaked at $12M in Q4 2013.
- 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.